NDC at the heart of beauty & wellness in Saudi Arabia
October 21, 2019

RIYADH — Beauty has boomed in Saudi Arabia and right in the center of it all is National Distribution Company (NDC), a distribution business based in the heart of Riyadh in Saudi Arabia. The market experts in all things beauty and wellness distribute over 25 international brands across KSA to bring major beauty, color cosmetics, haircare, nailcare and personal care to beauty-lovers in the country.

By distributing to over 50 retailers all over KSA,"...

Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease
October 21, 2019

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced results from a retrospective chart review study (EVOLVE), which investigated the likelihood of serious adverse events and serious infections with vedolizumab and anti-tumor necrosis factor-alpha (anti-TNFα) therapies in biologic-naïve patients with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD) in real-world clinical practice. These data were announced in an oral presentation at UEG Week 2019, held in Barcelona, Spain. Data from over 1,000 biologic-naïve patients with UC or CD receiving vedolizumab or an anti-TNFα therapy (adalimumab, infliximab, golimumab, or certolizumab pegol) were collected, with the incidence rate (per 100 person-years) for serious......

New Research Reveals Updated Patient Preferences on Digital Health Technology
October 19, 2019

ResMed (NYSE: RMD, ASX: RMD) today announced results from a company-led survey, revealing new patient preferences on digital health technology. The survey highlights a reason for optimism that the markets for digital health technology will only continue to grow.

The survey of a nationally representative sample of 3,000 Americans, conducted in partnership with Edelman Intelligence, revealed"...

Concept Medical is Granted CE Certification for Their Sirolimus Coated MagicTouch Group of Products
October 18, 2019

Concept Medical B.V. with its headquarters in Tampa, Florida has announced that on 16th October 2019, they have received the CE certification for their MagicTouch group of products. The CE certified products/brands are as listed below: MagicTouch – PTA (Sirolimus Coated PTA Balloon Catheter) for peripheral arterial disease MagicTouch – ED (Sirolimus Coated Balloon Catheter) for Erectile Dysfunction MagicTouch – AVF (Sirolimus Coated PTA Balloon Catheter) for Arterio-Venous Fistula and Graft MagicTouch – PTA is the only commercially available and CE certified Sirolimus coated balloon catheter for peripheral arterial diseases. Percutaneous transluminal angioplasty (PTA) is a procedure that can open a blocked blood vessel using a small catheter with a balloon at one end. The......

How Saudi Arabia is leading Middle East’s fight against breast cancer
October 17, 2019

ABU DHABI: Cancer of the breast remains the most common form of the disease among women despite major advances in treatment coupled with improved screening and awareness campaigns.

Rates of the disease are increasing in nearly every region globally as aging populations and factors such as obesity take their toll.

In"...

Johns Hopkins Center for Health Security, World Economic Forum and Bill & Melinda Gates Foundation Host Pandemic Exercise and Livestream
October 17, 2019

The Johns Hopkins Center for Health Security, with the World Economic Forum and the Bill & Melinda Gates Foundation, will host Event 201, a multimedia global pandemic exercise on Friday, Oct. 18, 2019, in New York City. The public may register and participate in the simultaneous virtual exercise in English, 8:50 a.m.-12:30 p.m. EDT at centerforhealthsecurity.org/event201/. The exercise underscores the need for global public-private cooperation to mitigate economic and societal impacts of severe pandemics. In recent years, the world has seen a growing number of epidemic events, about 200 per year, which strain limited resources. A large global pandemic would be disruptive to health, economies, and society. Economic studies show that pandemics could be the cause of an average annual economic loss of......

Boehringer Ingelheim Announces First Patient Enrolled in Phase II Trial of Novel Cystic Fibrosis Treatment (BALANCE-CFTM 1)
October 16, 2019

Boehringer Ingelheim today announced the first patient enrolled in its Phase II clinical trial BALANCE-CFTM 1 to evaluate a new potential treatment for cystic fibrosis.1,2 The trial will investigate how different doses of the compound, an inhaled epithelial sodium channel (ENaC) inhibitor, impact lung function compared to placebo when added to the standard of care in adults and adolescents with cystic fibrosis.1,3,4

People"...

Accomplishments of Dr. Steven Rosenberg in Cancer Immunotherapy Inspire Young Researchers in Japan & XIV Fujio Cup Quiz on Stem Cells Is Won by India.
October 16, 2019

Utilizing the capability of one’s own immune system to tackle cancer, an out-of-the box idea was the brain child of Dr. Steven Rosenberg almost three decades ago. His initiative which paved way for a new chapter in oncology, inspired many young scientists and clinicians in the NCRM NICHE 2019 held in Tokyo, Japan, as his acceptance speech in the Edogawa NICHE Prize ceremony was videocast.

NCRM"...

Regional clinical lab market worth $10bn, say experts
October 15, 2019

The region’s clinical laboratory services market is estimated to be worth around $8 - $10 billion growing at a CAGR of 6 per cent - 8 per cent until 2025, said the organisers of the upcoming Saudi Laboratory Congress in Jeddah, citing a Colliers International report.

The 2019 Saudi Laboratory and Diagnostics Congress will kick off tomorrow (October 13) placing prominence on the latest advancements and international guidelines in the medical laboratory"...

Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD
October 15, 2019

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa (NEMEA) countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of $200 million USD. This is the third transaction in FY19 that furthers Takeda’s"...